Search company, investor...

AspenBio Pharma

aspenbiopharma.com

Founded Year

2000

Stage

PIPE - II | IPO

Total Raised

$2.53M

About AspenBio Pharma

AspenBio Pharma is a Healthcare/Biotechnology company based in Castle Rock, Colorado. AspenBio Pharma's investors include Joshua Tree Asset Management, HealthCor Management, Corriente Advisors, Iroquois Capital and Ardsley Partners.

Headquarters Location

1585 South Perry Street

Castle Rock, Colorado, 80104,

United States

303-794-2000

Missing: AspenBio Pharma's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AspenBio Pharma's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

AspenBio Pharma Patents

AspenBio Pharma has filed 8 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/4/2004

10/23/2018

Progestogens, Human female endocrine system, Fertility medicine, Cattle breeds, G protein coupled receptors

Grant

Application Date

3/4/2004

Grant Date

10/23/2018

Title

Related Topics

Progestogens, Human female endocrine system, Fertility medicine, Cattle breeds, G protein coupled receptors

Status

Grant

Latest AspenBio Pharma News

Venaxis Inc. formerly AspenBio Pharma Inc. Mergers Acquisitions MA Partnerships Alliances and Investment Report Prices from USD $350

Nov 29, 2016

Advertisement Topics   Track topics on Twitter Track topics that are important to you Printed From BioPortfolio.com Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 07:24 EST 29 Nov 2016 | BioPortfolio Reports Home » Topics » Biotechnology Business » Latest News » Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350 Summary MarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Venaxis, Inc. formerly AspenBio Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes business description, detailed reports on mergers and acquisitions MA, divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Venaxis, Inc. formerly AspenBio Pharma, Inc. since January 2007. Key Findings Provides intelligence on Venaxis, Inc. formerly AspenBio Pharma, Inc. MA, strategic partnerships and alliances, capital raising and private equity transactions. Detailed reports of various financial transactions undertaken by Venaxis, Inc. formerly AspenBio Pharma, Inc. and its subsidiaries since 2007. Information about key financial and legal advisors for Venaxis, Inc. formerly AspenBio Pharma, Inc.'s financial deals transactions. Financial deals tables and charts covering deal value and volumes trend, deal types and geographybased deal activity. ReasonsToBuy Access comprehensive financial deals data along with charts and graph covering MA, private equity, and partnerships and alliances. Form an independent opinion about Venaxis, Inc. formerly AspenBio Pharma, Inc.'s growth strategies through the organic and inorganic activities undertaken since 2007. Track your competitors' business structure and growth strategies. Related Biotechnology, Pharmaceutical and Healthcare News

AspenBio Pharma Frequently Asked Questions (FAQ)

  • When was AspenBio Pharma founded?

    AspenBio Pharma was founded in 2000.

  • Where is AspenBio Pharma's headquarters?

    AspenBio Pharma's headquarters is located at 1585 South Perry Street, Castle Rock.

  • What is AspenBio Pharma's latest funding round?

    AspenBio Pharma's latest funding round is PIPE - II.

  • How much did AspenBio Pharma raise?

    AspenBio Pharma raised a total of $2.53M.

  • Who are the investors of AspenBio Pharma?

    Investors of AspenBio Pharma include Iroquois Capital Group, Joshua Tree Asset Management, Corriente Advisors, HealthCor Management, Ardsley Partners and 3 more.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.